BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133,331 | +27.6% | 18,832 | +26.9% | 0.01% | +25.0% |
| Q2 2023 | $104,488 | -15.6% | 14,842 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $123,782 | -21.5% | 14,842 | 0.0% | 0.01% | -16.7% |
| Q4 2022 | $157,770 | -9.8% | 14,842 | +6.5% | 0.01% | -25.0% |
| Q3 2022 | $175,000 | +19.0% | 13,940 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $147,000 | -35.2% | 13,940 | 0.0% | 0.01% | -25.0% |
| Q1 2022 | $227,000 | +17.6% | 13,940 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $193,000 | -3.5% | 13,940 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $200,000 | -9.1% | 13,940 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $220,000 | +43.8% | 13,940 | -7.4% | 0.01% | +33.3% |
| Q1 2021 | $153,000 | +36.6% | 15,052 | 0.0% | 0.01% | +20.0% |
| Q4 2020 | $112,000 | +115.4% | 15,052 | 0.0% | 0.01% | +150.0% |
| Q3 2020 | $52,000 | -14.8% | 15,052 | +18.2% | 0.00% | -33.3% |
| Q2 2020 | $61,000 | +144.0% | 12,730 | 0.0% | 0.00% | +200.0% |
| Q1 2020 | $25,000 | -43.2% | 12,730 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $44,000 | +83.3% | 12,730 | +53.4% | 0.00% | +100.0% |
| Q3 2019 | $24,000 | -22.6% | 8,297 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $31,000 | -54.4% | 8,297 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $68,000 | +1.5% | 8,297 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $67,000 | +6.3% | 8,297 | 0.0% | 0.00% | +33.3% |
| Q3 2018 | $63,000 | +31.2% | 8,297 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $48,000 | +20.0% | 8,297 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $40,000 | +21.2% | 8,297 | +23.9% | 0.00% | 0.0% |
| Q4 2017 | $33,000 | -2.9% | 6,697 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $34,000 | -8.1% | 6,697 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $37,000 | -21.3% | 6,697 | +19.7% | 0.00% | 0.0% |
| Q1 2017 | $47,000 | – | 5,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |